Department of Cardiology, Angiology, and Pneumology (M.B.H., F.R., D.F., H.A.K., F.L., L.H.L.), Heidelberg University Hospital, Germany.
German Centre for Cardiovascular Research (DZHK), Heidelberg/Mannheim partner site, Germany (M.B.H., F.R., D.F., H.A.K., F.L., L.H.L.).
Circ Cardiovasc Imaging. 2020 Sep;13(9):e010628. doi: 10.1161/CIRCIMAGING.120.010628. Epub 2020 Sep 11.
FAP (fibroblast activation protein) plays an important role in cardiac wound healing and remodeling. Although initially developed as a theranostic ligand for metastasized cancer, FAPI (FAP inhibitor) tracers have recently been used to study cardiac remodeling following myocardial infarction in small-animal models. The aim of the study was to evaluate the activity of FAP via FAPI-positron emission tomography-computed tomography scans in human hearts.
FAPI-positron emission tomography-computed tomography scans of 229 patients of 2 consecutive cohorts (modeling cohort: n=185; confirmatory cohort: n=44) suffering from metastasized cancer were analyzed applying the American Heart Association 17-segment model of the left ventricle. Logistic regression models were created using data from the modeling cohort. Multivariate regression models were established using Akaike information criterion in a step-down approach.
Fourteen percent of patients had preexisting coronary artery disease (n=31), 33% arterial hypertension (n=75), and 12% diabetes mellitus type II (n=28). Forty-three percent had been treated with platin derivatives (n=100), 14% with anthracyclines (n=32), and 10% had a history of prior radiation to the chest (n=23). High left ventricular FAPI signals correlated with the presence of cardiovascular risk factors (odds ratio [OR], 4.3, =0.0029), a focal myocardial signal pattern (OR, 3.9, =0.0068), diabetes mellitus type II (OR, 4.1, =0.046), and beta-blocker use (OR, 3.8, =0.049) in univariate regression models. In a multivariate analysis, increased signal intensity was significantly higher in patients with cardiovascular risk factors (overweight [OR, 2.6, =0.023], diabetes mellitus type II [OR, 2.9, =0.041], certain chemotherapies [platinum derivatives; OR, 3.0, =0.034], and a history of radiation to the chest [OR, 3.5, =0.024]). A focal enrichment pattern was more frequently observed in patients with known cardiovascular risk factors (<0.0001).
FAPI-positron emission tomography-computed tomography scans represent a new imaging modality to investigate cardiac FAP. High signal intensities correlate with cardiovascular risk factors and metabolic disease.
成纤维细胞激活蛋白(fibroblast activation protein,FAP)在心脏创伤愈合和重塑中起着重要作用。尽管最初被开发为转移性癌症的治疗诊断配体,但 FAPI(FAP 抑制剂)示踪剂最近已被用于研究小型动物模型中心肌梗死后的心脏重塑。本研究旨在通过 FAPI 正电子发射断层扫描-计算机断层扫描(positron emission tomography-computed tomography,PET-CT)评估人类心脏中的 FAP 活性。
对连续 2 个队列(建模队列:n=185;验证队列:n=44)中患有转移性癌症的 229 名患者的 FAPI-PET-CT 扫描进行分析,采用美国心脏协会(American Heart Association)左心室 17 节段模型。使用建模队列的数据创建逻辑回归模型。使用逐步降维方法的赤池信息量准则(Akaike information criterion)建立多变量回归模型。
14%的患者(n=31)存在预先存在的冠状动脉疾病,33%(n=75)患有动脉高血压,12%(n=28)患有 2 型糖尿病。43%(n=100)接受过顺铂衍生物治疗,14%(n=32)接受过蒽环类药物治疗,10%(n=23)曾接受过胸部放疗。左心室 FAPI 信号升高与心血管危险因素(比值比[odds ratio,OR],4.3,=0.0029)、局灶性心肌信号模式(OR,3.9,=0.0068)、2 型糖尿病(OR,4.1,=0.046)和β受体阻滞剂的使用(OR,3.8,=0.049)相关。在多变量分析中,心血管危险因素患者的信号强度显著升高(超重[OR,2.6,=0.023]、2 型糖尿病[OR,2.9,=0.041]、特定化疗药物[顺铂衍生物;OR,3.0,=0.034]和胸部放疗史[OR,3.5,=0.024])。在已知有心血管危险因素的患者中,局灶性富集模式更为常见(<0.0001)。
FAPI-PET-CT 扫描代表了一种新的心脏 FAP 成像方式。高信号强度与心血管危险因素和代谢性疾病相关。